Search


 
Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 18 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
Oct-2009Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.Rudinskiy, N; Kaneko, YA; Beesen, AA; Gokce, O; Régulier, E; Déglon, N; Luthi-Carter, RJournal Article
Jul-2010Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.Wu, F; Schweizer, C; Rudinskiy, N; Taylor, DM; Kazantsev, A; Luthi-Carter, R; Fraering, PCJournal Article
15-Apr-2010Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.Becanovic, K; Pouladi, MA; Lim, RS; Kuhn, A; Pavlidis, P; Luthi-Carter, R; Hayden, MR; Leavitt, BRJournal Article
Apr-2010Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.Thu, DC; Oorschot, DE; Tippett, LJ; Nana, AL; Hogg, VM; Synek, BJ; Luthi-Carter, R; Waldvogel, HJ; Faull, RLJournal Article
1-Aug-2007Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.Kuhn, A; Goldstein, DR; Hodges, A; Strand, AD; Sengstag, T; Kooperberg, C; Becanovic, K; Pouladi, MA; Sathasivam, K; Cha, JH; Hannan, AJ; Hayden, MR; Leavitt, BR; Dunnett, SB; Ferrante, RJ; Albin, R; Shelbourne, P; Delorenzi, M; Augood, SJ; Faull, RL; Olson, JM; Bates, GP; Jones, L; Luthi-Carter, RJournal Article
15-Mar-2006Regional and cellular gene expression changes in human Huntington's disease brain.Hodges, A; Strand, AD; Aragaki, AK; Kuhn, A; Sengstag, T; Hughes, G; Elliston, LA; Hartog, C; Goldstein, DR; Thu, D; Hollingsworth, ZR; Collin, F; Synek, B; Holmans, PA; Young, AB; Wexler, NS; Delorenzi, M; Kooperberg, C; Augood, SJ; Faull, RL; Olson, JM; Jones, L; Luthi-Carter, RJournal Article
Feb-2006Capucin: a novel striatal marker down-regulated in rodent models of Huntington disease.de Chaldée M; Brochier, C; Van de Vel A; Caudy, N; Luthi-Carter, R; Gaillard, MC; Elalouf, JMJournal Article
15-May-2007Modulation of nucleosome dynamics in Huntington's disease.Stack, EC; Del Signore SJ; Luthi-Carter, R; Soh, BY; Goldstein, DR; Matson, S; Goodrich, S; Markey, AL; Cormier, K; Hagerty, SW; Smith, K; Ryu, H; Ferrante, RJJournal Article
Jan-2012Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.Jiang, M; Wang, J; Fu, J; Du, L; Jeong, H; West, T; Xiang, L; Peng, Q; Hou, Z; Cai, H; Seredenina, T; Arbez, N; Zhu, S; Sommers, K; Qian, J; Zhang, J; Mori, S; Yang, XW; Tamashiro, KL; Aja, S; Moran, TH; Luthi-Carter, R; Martin, B; Maudsley, S; Mattson, MP; Cichewicz, RH; Ross, CA; Holtzman, DM; Krainc, D; Duan, WJournal Article
17-Oct-2008The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.Jan, A; Gokce, O; Luthi-Carter, R; Lashuel, HAJournal Article